Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 102,668	$ 105,933
Accounts receivable, net of allowances of $810 and $780, respectively	9,012	9,268
Inventory	11,672	12,107
Prepaid expenses and other current assets	2,782	2,505
Total current assets	126,134	129,813
Property and equipment, net	2,435	2,505
Operating lease right-of-use asset	994	1,069
Other non-current assets	26	27
Total assets	129,589	133,414
Current liabilities:
Accounts payable	2,751	2,582
Accrued expenses	5,757	8,180
Total current liabilities	8,508	10,762
Long-term debt	49,332	49,273
Operating lease liability, non-current portion	802	877
Other long-term liabilities	1,587	1,447
Total liabilities	60,229	62,359
Commitments and contingencies (Note 10)
Stockholders' equity:
Common stock, $0.01 par value, 200,000,000 authorized as of March 31, 2025 and December 31, 2024; 26,051,992 and 25,324,684 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively	261	253
Additional paid-in capital	620,416	608,354
Accumulated deficit	(551,112)	(537,346)
Accumulated other comprehensive loss	(205)	(206)
Total stockholders' equity	69,360	71,055
Total liabilities and stockholders' equity	$ 129,589	$ 133,414